Submitted by Anonymous (not verified) on 3 March 2026 - 15:35
Human medicines European public assessment report (EPAR): Afqlir, aflibercept, Date of authorisation: 13/11/2024, Revision: 6, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Afqlir, aflibercept, Date of authorisation: 13/11/2024, Revision: 6, Status: Authorised